Glucocorticoid toxicity reduction with mepolizumab using the Glucocorticoid Toxicity Index

by Butler, C.A, Dunn, L., Heaney, L.G, Honeyford, K., Jane McDowell, P., Jayne Logan, R., McGarvey, L.P.A, Stone, J.H, Zhang, Y.
Published 2022

Efficacy of Inhaled Ciclesonide for Outpatient Treatment of Adolescents and Adults with Symptomatic COVID-19: A Randomized Clinical Trial

by Blaiss, M.S, Clemency, B.M, Gonzalez-Rojas, Y., Koster, D.J, Morse, C.G, Phipatanakul, W., Varughese, R.
Published 2022

Inebilizumab for treatment of neuromyelitis optica spectrum disorder in patients with prior rituximab use from the N-MOmentum Study

by Cimbora, D., Cree, B.A.C, Drappa, J., Flanagan, E.P, Katz, E., Levy, M., Mealy, M.A, She, D.
Published 2022

The Landscape of COVID-19 Research in the United States: a Cross-sectional Study of Randomized Trials Registered on ClinicalTrials.Gov

by Campbell, K.R, Dougan, M., Fralick, M., Moggridge, J., North, C.M, Sacks, C.A, Wolf, M.
Published 2022

Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID-19 - United States, March 2020-August 2021

by Block, J.P, Boehmer, T.K, Carton, T.W, Denson, J.L, Feehan, A.K, Gundlapalli, A., Hall, J., Koumans, E., Ladva, C.N, Molinari, N.A.M, Rasmussen, S.A, Trick, W.E, Truman, B.I, Weiner, M.G, Wiltz, J.L
Published 2022

Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia

by Auclair, D., Ferrari, F., Fischer, E.S, Ghobrial, I.M, Hamilton, M., Horowitz, E., Justis, A.V, Konishi, Y., Lightbody, E.D, Marinac, C.R, Nowak, R.P, Perry, J., Prescott, J., Redd, R.A, Russo, M., Savell, A., Shayegh, N.A, Sklavenitis-Pistofidis, R., Trippa, L., Varmeh, S., Yue, H.
Published 2022

Diagnostic and therapeutic potential of shark variable new antigen receptor (VNAR) single domain antibody

by Abdul Majeed, A.B, Cheong, W.S, Leow, C.H, Leow, C.Y
Published 2020

Loss of human leucocyte antigen class I and gain of class II expression are early events in carcinogenesis: Clues from a study of Barrett's oesophagus

by Ackroyd, R., Ho, J.J, Karim, N., Kutty, M.K, Mohan, C., Rajendra, S.

Inhibition of matrix metalloproteinase-2 modulates malignant behaviour of oral squamous cell carcinoma cells

by Celentano, A., Cirillo, N., Koo, K., McCullough, M., Mirams, M., Paolini, R., Yap, T., Yiannis, C.
Published 2021

A tale in three parts: The success of California’s life science clusters

by Panetta, J.
Published 2021

Exacerbation Rate Reduction With Mepolizumab Stratified by Maintenance Oral Corticosteroids Use and Eosinophil Levels: A Post Hoc Analysis of the DREAM and MENSA Studies

by Bañas, D., Bobolea, I., de Andrés, A.I, Joksaite, S., Melero, C., Sánchez-Herrero, G.
Published 2022

Use of Dupilumab in 543 Adult Patients With Moderate-to-Severe Atopic Dermatitis: A Multicenter, Retrospective Study

by Argenziano, G., Bonzano, L., Calabrese, G., Carbonara, M., Detoraki, C., Di Bona, D., Di Leo, E., Fabbrocini, G., Ferrucci, S.M, Foti, C., Macchia, L., Napolitano, M., Nettis, E., Nisticò, S.P, Ortoncelli, M., Patruno, C., Pellacani, G., Piras, V., Ribero, S., Romita, P., Rongioletti, F., Tavecchio, S.
Published 2022

Channeling effects in the prescription of new therapies: the case of emicizumab for hemophilia A

by Chang, T., Faghmous, I., Flores, C., Howard, M., Kuebler, P., Mahajerin, A., Nissen, F., Xu, T.
Published 2022

Injection-Site Reaction to Brodalumab in a Psoriasis Patient: Report of Clinicopathological Findings

by Huang, I.-H, Huang, Y.-W, Liau, J.-Y, Tsai, T.-F
Published 2022